Cover Image
市場調查報告書

胃水球市場預測:液體填充型·空氣填充型

Intragastric Balloons Market: By Balloon Type (Fluid-Filled, Air-Filled); By Geography (Americas, Europe, APAC, RoW) - (2016-2021)

出版商 IndustryARC 商品編碼 622638
出版日期 內容資訊 英文 144 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胃水球市場預測:液體填充型·空氣填充型 Intragastric Balloons Market: By Balloon Type (Fluid-Filled, Air-Filled); By Geography (Americas, Europe, APAC, RoW) - (2016-2021)
出版日期: 2017年08月17日 內容資訊: 英文 144 Pages
簡介

本報告提供全球胃水球的市場調查,彙整市場定義和概要,競爭環境與市場佔有率,產品基準,市場的各種影響因素及市場機會分析,價值鏈,治療類型·地區/各主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 競爭分析
  • 產品基準
  • 終端用戶的簡介
  • 前五名公司的財務分析

第4章 市場影響因素

  • 成長推進因素
  • 阻礙成長要素
  • 市場機會
  • 市場課題
  • 波特的五力分析

第5章 策略性市場分析

  • 價值鏈分析
  • 價格分析
  • 市場機會分析
  • 產品·市場生命週期
  • 供應商·流通經銷商

第6章 胃水球市場分析·預測:治療類別

  • 內視鏡的胃水球
  • ReShape Duo
  • Abalon

第7章 胃水球市場分析·預測:各地區

  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 其他地區
    • 巴西
    • 其他

第8章 市場熵

  • 擴張
  • 技術開發
  • M&A·JV
  • 供給契約

第9章 企業簡介

  • Apollo Endosurgery
  • Helioscopie Medical Implants
  • Spatz FGIA Inc
  • Allurion technologies
  • Districlass Medical SA
  • Endalis
  • Fengh Medical
  • Lexal Srl
  • Life Partners Europe
  • Medicone
  • Medsil
  • Obalon Therapeutics
  • Phagia Technologies
  • PlenSat
  • ReShape Medical

第10章 附錄

目錄

Intragastric Balloons is a medical procedure which includes inserting of uninflated balloons with the help of endoscopes and then inflate the balloons in the stomach by filling it with saline solution to decrease the available stomach volume and partially filling the stomach. Intragastric balloon procedure is used in morbid obesity cases to decrease hunger and is helpful for patients who cannot lose weight by any other means and are prone to serious health problems related to obesity. As per WHO, 39% of adult population (aged 18 years and above) were overweight in 2014, and 13% were obese. Obesity has received considerable attention as a major health hazard as it leads to adverse metabolic effects such as High Blood Pressure, Diabetes, Coronary Heart Disease and Ischemic stroke. Globally, increasing obese population as a result of changing life style and increasing cases of obesity related health issues are expected to remain the prime growth drivers for intragastric balloons during the period of study.

Geographically, North America dominated the intragastric balloons market driven by world class healthcare infrastructure with technological advanced practice, higher spending, large population with obesity and related diseases and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for intragastric balloons. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the intragastric balloons market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the intragastric balloons market.

This report segments the intragastric balloons market on the basis of treatment type and regional market as follows:

Intragastric balloons market research report is classified on the basis of treatment type. Some of the major intragastric treatment types covered in this report are as follows: Endoscopic Intagastric balloon, ReShape Duo, Abalon or Balloon Pill.

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the intragastric balloons market. Some of the major companies' profiles in detail are as follows:

Apollo Endosurgery

Helioscopie Medical Implants

Spatz FGIA Inc

Allurion technologies

Districlass Medical SA

1. Intragastric balloons Market - Overview

2. Executive Summary

3. Intragastric balloons Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Intragastric balloons Market- Forces

  • 4.1. Drivers
    • 4.1.1. Globally increasing population of obese people
    • 4.1.2. Preference of MSI over open surgery
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Intragastric balloons Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Intragastric balloons Market, By Treatment type

  • 6.1. Endoscopic Intagastric balloon
  • 6.2. ReShape Duo
  • 6.3. Abalon

7. Intragastric balloons Market, By Geography

  • 7.1. Europe
    • 7.1.1. Germany
    • 7.1.2. France
    • 7.1.3. Italy
    • 7.1.4. Spain
    • 7.1.5. Russia
    • 7.1.6. U.K.
    • 7.1.7. Rest of Europe
  • 7.2. Asia Pacific
    • 7.2.1. China
    • 7.2.2. India
    • 7.2.3. Japan
    • 7.2.4. South Korea
    • 7.2.5. Rest of Asia-Pacific
  • 7.3. North America
    • 7.3.1. U.S.
    • 7.3.2. Canada
    • 7.3.3. Mexico
  • 7.4. Rest of the World (RoW)
    • 7.4.1. Brazil
    • 7.4.2. Rest of RoW

8. Intragastric balloons Market - Entropy

  • 8.1. Expansion
  • 8.2. Technological Developments
  • 8.3. Merger & Acquisitions, and Joint Ventures
  • 8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 9.1. Apollo Endosurgery
  • 9.2. Helioscopie Medical Implants
  • 9.3. Spatz FGIA Inc
  • 9.4. Allurion technologies
  • 9.5. Districlass Medical SA
  • 9.6. Endalis
  • 9.7. Fengh Medical
  • 9.8. Lexal Srl
  • 9.9. Life Partners Europe
  • 9.10. Medicone
  • 9.11. Medsil
  • 9.12. Obalon Therapeutics
  • 9.13. Phagia Technologies
  • 9.14. PlenSat
  • 9.15. ReShape Medical.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

10. Appendix

  • 10.1. Abbreviations
  • 10.2. Sources
  • 10.3. Research Methodology
  • 10.4. Bibliography
  • 10.5. Compilation of Expert Insights
  • 10.6. Disclaimer
Back to Top